Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 839 of 1,261

  1. US 8604064

    Process for the preparation of roflumilast

    TAKEDA GMBH · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  2. US 8604023

    1,4-benzodiazepinone compounds and their use in treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  3. US 8604033

    Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  4. US 8604203

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  5. US 8604244

    Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives

    REVIVA PHARMACEUTICALS, INC. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  6. US 8604058

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  7. US 8603808

    Leishmania vaccine using sand fly salivary immunogen

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  8. US 8603978

    Use of muramyl dipeptide (MDP) for treating inflammation

    The United States of America, as represented by the Secretary, Department of Health and Humand Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  9. US 8604011

    Therapy for treatment of chronic degenerative brain diseases and nervous system injury

    The Regents of the University of California · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  10. US 8603819

    Compositions and methods for generating musculoskeletal tissue

    The Regents of the University of California · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  11. US 8603468

    Neutralization of HCV

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  12. US 8603543

    Mesocellular oxide foams as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  13. US 8603456

    Method of treating hair loss with compositions containing interleukin-1

    United Technologies UT AG · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  14. US 8598322

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  15. US 8597946

    Enhanced dendritic cells for cancer immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  16. US 8597655

    Recombinant fusion protein and polynucleotide construct for immunotoxin production

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  17. US 8597616

    Dry powder drug delivery formulations, methods of use, and devices therefore

    The Board of Regents of the University of Texas System · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  18. US 8598364

    Oligomer-protease inhibitor conjugates

    Nektar Therapeutics · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  19. US 8598361

    Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof

    Vertex Pharmaceuticals Incorporated · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  20. US 8598321

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  21. US 8598333

    SiRNA silencing of genes expressed in cancer

    Alnylam Pharmaceuticals, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  22. US 8598312

    Inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  23. US 8598313

    Compositions for ameliorating cell proliferative disorders and methods of making and using them

    The Regents of the University of California · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  24. US 8598226

    Fused cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.